Is Uber Finally on the Path to Consistent Profitability?
After posting massive losses quarter after quarter for years, Uber…
Sell
34
BAYRY Quote, Financials, Valuation and Earnings
Last price:
$5.91
Seasonality move
:
0.88%
Day range:
$5.85 - $5.92
52-week range:
$4.79 - $8.58
Dividend yield:
0.5%
P/E ratio:
--
P/S ratio:
0.46x
P/B ratio:
0.70x
Volume:
302.2K
Avg. volume:
696.5K
1-year change:
-16.24%
Market cap:
$23.1B
Revenue:
$50.4B
EPS (TTM):
-$0.72
Analysts' Opinion
-
Consensus RatingBayer AG has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $8.32, Bayer AG has an estimated upside of 41.5% from its current price of $5.88.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $7.16 representing 100% downside risk from its current price of $5.88.
Fair Value
-
According to the consensus of 3 analysts, Bayer AG has 41.5% upside to fair value with a price target of $8.32 per share.
BAYRY vs. S&P 500
-
Over the past 5 trading days, Bayer AG has overperformed the S&P 500 by 4.74% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Bayer AG does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Bayer AG revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Bayer AG reported revenues of $12.5B.
Earnings Growth
-
Bayer AG earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Bayer AG reported earnings per share of -$0.09.
Enterprise value:
55.9B
EV / Invested capital:
--
Price / LTM sales:
0.46x
EV / EBIT:
9.59x
EV / Revenue:
1.11x
PEG ratio (5yr expected):
--
EV / Free cash flow:
11.25x
Price / Operating cash flow:
4.65x
Enterprise value / EBITDA:
5.86x
Gross Profit (TTM):
$27.4B
Return On Assets:
-2.27%
Net Income Margin (TTM):
-5.6%
Return On Equity:
-7.79%
Return On Invested Capital:
-5.26%
Operating Margin:
30.11%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $53.7B | $51.5B | $50.4B | $12.8B | $12.5B | |
| Gross Profit | $32.7B | $30.2B | $27.4B | $7.9B | $6.4B | |
| Operating Income | $7.9B | $8.6B | $3.5B | $10.4B | $3.8B | |
| EBITDA | $13.9B | $11.3B | $9.5B | $2.4B | $1.8B | |
| Diluted EPS | $1.16 | -$0.83 | -$0.72 | $0.37 | -$0.09 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $43.9B | $36.9B | $40.5B | $41.5B | $35.8B | |
| Total Assets | $143.7B | $136.1B | $133.9B | $128.5B | $115.3B | |
| Current Liabilities | $45.2B | $33.3B | $37.6B | $32.6B | $30.1B | |
| Total Liabilities | $105.9B | $98.6B | $92.2B | $91.9B | $82B | |
| Total Equity | $37.7B | $37.6B | $41.7B | $36.6B | $33.3B | |
| Total Debt | $49.7B | $43.4B | $43B | $46B | $41B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $7.5B | $5.5B | $8B | $6.1B | $5.4B | |
| Cash From Investing | -$2.5B | -$3.8B | $177.5M | -$4.2B | -$1.4B | |
| Cash From Financing | -$4.5B | -$735.1M | -$7.8B | -$2.7B | -$2.2B | |
| Free Cash Flow | $4.4B | $2.6B | $5B | $5B | $4.2B | |
BAYRY
Sector
Market Cap
$23.1B
$35M
Price % of 52-Week High
68.53%
41.88%
Dividend Yield
0.5%
0%
Shareholder Yield
--
-0.91%
1-Year Price Total Return
-16.24%
-43.29%
Beta (5-Year)
0.939
0.743
Dividend yield:
0.5%
Annualized payout:
$0.03
Payout ratio:
-5.03%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$5.69
200-day SMA
Sell
Level
$6.46
Bollinger Bands (100)
Buy
Level
5.06 - 6.08
Chaikin Money Flow
Buy
Level
99.5M
20-day SMA
Sell
Level
$5.99
Relative Strength Index (RSI14)
Sell
Level
48.15
ADX Line
Sell
Level
15.52
Williams %R
Neutral
Level
-36.9565
50-day SMA
Sell
Level
$5.97
MACD (12, 26)
Sell
Level
-0.09
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Sell
Level
-87.1M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-1.2874)
Buy
Beneish M-Score
(Annual)
Level (-2.9701)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.0271)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm's crop science business sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
Stock Forecast FAQ
In the current month, BAYRY has received 1 Buy ratings 2 Hold ratings, and 0 Sell ratings. The BAYRY average analyst price target in the past 3 months is $8.32.
-
Where Will Bayer AG Stock Be In 1 Year?
According to analysts, the consensus estimate is that Bayer AG share price will rise to $8.32 per share over the next 12 months.
-
What Do Analysts Say About Bayer AG?
Analysts are divided on their view about Bayer AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bayer AG is a Sell and believe this share price will drop from its current level to $7.16.
-
What Is Bayer AG's Price Target?
The price target for Bayer AG over the next 1-year time period is forecast to be $8.32 according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is BAYRY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Bayer AG is a Hold. 2 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of BAYRY?
You can purchase shares of Bayer AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bayer AG shares.
-
What Is The Bayer AG Share Price Today?
Bayer AG was last trading at $5.91 per share. This represents the most recent stock quote for Bayer AG. Yesterday, Bayer AG closed at $5.88 per share.
-
How To Buy Bayer AG Stock Online?
In order to purchase Bayer AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will MSTY Go By 2030?
YieldMax’s MSTR Option Income Strategy ETF (MSTY) is a high-yield…
Will NVIDIA Stock Bounce Back?
After the wild market moves during February and March, investors…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
45
DSDVY alert for Apr 16
DSV AS [DSDVY] is down 2.69% over the past day.
Buy
76
PDEX alert for Apr 16
Pro-Dex [PDEX] is down 4.66% over the past day.
Buy
82
HAGHY alert for Apr 16
Hensoldt AG [HAGHY] is down 0.02% over the past day.
